The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Synthetic Biologics, Inc. - Late-stage Clinical Company Developing Therapeutics to Preserve the Microbiome

SNNLive spoke with Jeff Riley, CEO of Synthetic Biologics, Inc. (NYSE MKT: SYN) at the BioMaryland Pavilion at the BIO International Convention 2017 in San Diego, CA.

Share With

Wednesday, September 06, 2017

   

© 2017 Stock News Now